NovoCure (NVCR) Capital Expenditures (2014 - 2026)
NovoCure (NVCR) posted Capital Expenditures of $6.9 million for Q2 2026, up 34.24% sequentially from $5.2 million in Q1 2026, and up 26.07% YoY from $5.5 million in Q2 2025.
NovoCure (NVCR) Capital Expenditures (2014 - 2026) Analysis & Trends
NovoCure has reported Capital Expenditures for 13 years, with the latest figure at $6.9 million in Q2 2026.
- Quarterly Capital Expenditures rose 26.07% year-over-year to $6.9 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $22.6 million (down 36.68% YoY) and the FY2025 annual result came in at $26.6 million, down 37.82% from the prior year.
- Capital Expenditures grew to $6.9 million in Q2 2026 per NVCR's latest filing, from $5.2 million in the prior quarter.
- Over five years, Capital Expenditures peaked at $11.8 million in Q1 2024 and troughed at $4.1 million in Q2 2022.
- A 5-year average of $7.2 million and a median of $6.6 million in 2022 frame the typical range for Capital Expenditures.
- The sharpest annual moves came in 2022 and 2024: Capital Expenditures tumbled 54.95% in 2022, then soared 93.56% in 2024.
- Over 5 years, Capital Expenditures stood at $6.4 million in 2022, then climbed by 6.06% to $6.8 million in 2023, then surged by 31.1% to $8.9 million in 2024, then sank by 45.25% to $4.9 million in 2025, then surged by 41.26% to $6.9 million in 2026.
- According to Business Quant data, Capital Expenditures over the past three periods registered $6.9 million, $5.2 million, and $4.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 497.00 Mn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 202.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 488.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 195.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 66.90 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 84.70 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 100.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -74.39 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 87.50 Mn |
| 10 | NovoCure | 1.99 Bn | 1.55 Bn | 142.48 Mn | 6.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.92 Mn |
| Jun 30, 2026 | 6.92 Mn |
| Mar 31, 2026 | 5.15 Mn |
| Mar 31, 2026 | 5.15 Mn |
| Dec 31, 2025 | 4.90 Mn |
| Dec 31, 2025 | 4.90 Mn |
| Sep 30, 2025 | 5.66 Mn |
| Sep 30, 2025 | 5.66 Mn |
| Jun 30, 2025 | 5.49 Mn |
| Jun 30, 2025 | 5.49 Mn |
| Mar 31, 2025 | 10.61 Mn |
| Mar 31, 2025 | 10.61 Mn |
| Dec 31, 2024 | 8.94 Mn |
| Dec 31, 2024 | 8.94 Mn |
| Sep 30, 2024 | 10.68 Mn |
| Sep 30, 2024 | 10.68 Mn |
| Jun 30, 2024 | 11.45 Mn |
| Jun 30, 2024 | 11.45 Mn |
| Mar 31, 2024 | 11.78 Mn |
| Mar 31, 2024 | 11.78 Mn |